Natus Medical Inc (BABY.OQ)
BABY.OQ on NASDAQ Stock Exchange Global Select Market
13.64USD
1 Aug 2013
13.64USD
1 Aug 2013
Price Change (% chg)
$0.85 (+6.65%)
$0.85 (+6.65%)
Prev Close
$12.79
$12.79
Open
$12.95
$12.95
Day's High
$13.73
$13.73
Day's Low
$12.52
$12.52
Volume
32,713
32,713
Avg. Vol
55,553
55,553
52-wk High
$15.18
$15.18
52-wk Low
$9.65
$9.65
About
Natus Medical Incorporated (Natus) is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The Company’s product offerings... (more)
Overall
| Beta: | 1.36 |
| Market Cap (Mil.): | $388.65 |
| Shares Outstanding (Mil.): | 30.39 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| BABY.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 59.17 | 66.39 | 37.76 |
| EPS (TTM): | 0.22 | -- | -- |
| ROI: | 2.45 | 4.99 | 18.76 |
| ROE: | 2.62 | 9.80 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Cardica, Inc. (CRDC.OQ) | $1.19 | +0.01 |
| Ophthalmic Imaging Systems (OISI.OB) | -- | -- |
| Guided Therapeutics Inc (GTHP.OB) | $0.69 | +0.00 |
| Johnson & Johnson (JNJ.N) | $94.11 | +0.61 |
| Thermo Fisher Scientific Inc. (TMO.N) | $92.37 | +1.26 |
| Becton, Dickinson and Co. (BDX.N) | $102.37 | -1.35 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

